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Abstract 
Back ground: Gastric malignancies carry poor prognosis, because they commonly present at an 
advanced stage. 
Objective: to find out mode of presentation and its impact on the outcome and management of 
gastric cancer and to find if there are changes in trends of gastric malignancies over the last decade.  
Patients and methods: A review of 53 patients with gastric malignancies, treated at Ibn Sina 
Hospital from August 2010 through August 2011. Their demographic data, pattern of clinical 
presentation, histopathology grading and staging, type of management and hospital mortality were 
studied. 
Statistical analysis: Data was fed to Statistical Package for Social Sciences. Means and 
correlations were computed where appropriate. One sample t-test was performed. Statistical 
significance was taken at P = 0.05. 
 Results: Out of 53 patients males comprise 30(56.6%) males. The peak frequency was at the age 
group 55-70 years. Patients from the Northern Region of Sudan constituted 34%. Adenocarcinoma 
comprised 43(81.3%), GIST 8(15%), lymphoma 1(1.9%) and carcinoid 1(1.9%). Epigastric pain 
was the commonest symptom in 47(88.7%) patients. Smoking and snuff (Tombak) and high salt 
diet were found in 7.5% and 5.7% and 3.8% patients respectively. Blood group A and O was found 
in 22.6% and 60.4% respectively. Family cancer syndrome was found in 11.3% patients. 
Malignancies of the antrum constitute 27(65.85%), cardia 4(9.8%), body 7(17.1%), and whole 
stomach 3(7.3%) patients. There were only 6.25% clinically early cases.  Potentially curative 
resection was attempted in 31.7%. The mean hospital stay was 12 days.  
 Conclusion: Patients presented at stage III and IV comprise 30 (93.75%) out of 32 carcinoma 
patients. The hospital morbidity was 13(24.6%) patients and mortality 4(7.5%) patients. When 
compared with results from same hospital there is improvement in outcome over a decade. 
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astric cancer is the fourth most 
common cancer worldwide (after 
lung, breast and colorectal cancer)1 It 
is the second common cause of cancer death 
worldwide2. The risk of developing gastric 
cancer was relatively lower in the Middle  
East and North Africa compared with those of 
western countries3.
In 1976 Malik MO et al reported gastric 
cancer as the third GIT cancer in Sudan. 
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He found the male to female ratio to be 2:1 
with peak frequency rate at the age group 50-
70 years4.
This study intended to find if there are 
changes in trends of gastric malignancies. Ibn 
Sina specialized Hospital was selected to be 
the site for our study because it has a 
specialized centre for gastrointestinal and 
liver diseases.  
 
Objectives: 
to find out mode of presentation and its 
impact on the outcome and management of 
gastric cancer and to find if there are changes 
in trends of gastric malignancies over the last 
decade. 
G
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Patients and methods: 
This is a hospital based, non-randomized, 
prospective case series study for gastric 
malignancies. 
Set up: Ibn Sina Specialized Hospital was 
established as a donation from the Japan 
International Corporation Agency (JICA) in 
1983. The hospital has a specialized centre for 
gastrointestinal and liver diseases.  
Period of study: From August 2010 through 
August 2011. 
Methods: Patients were interviewed, 
examined; details of the results of 
investigations and operative data as well as 
the hospital mortality rate were collected. 
Results were then correlated with results of 
data published from the same hospital a 
decade ago.    
Inclusion Criteria: All patients who proved 
to have gastric malignancy during the study 
period were included in the study. 
Exclusion Criteria: Cases with missed 
histopathological confirmation. 
Variables in the study: Demographic data, 
diet; social habits such as smoking, snuffing 
and alcohol consumption were obtained. 
Associated co-morbidities were included. 
Family history of gastric cancer and other 
familial cancer syndromes were also noted. 
Clinical examination was performed and 
notes were taken on cachexia, pallor, weight, 
presence of palpable abdominal mass and 
signs of metastasis such as Sister Mary 
Joseph nodule, Plummer shelf and/or 
Virchow’s lymph node. Results of CBC, 
urinalysis, blood group,  LFT , RFT, ECG, 
CXR and the endoscopic findings of the site 
and naked eye appearance.  
Testing for H.pylori through “CLO” test was 
also and CT-scan findings were gathered. 
Detailed intra – operative findings were 
obtained The tumour size was categorized 
into less than 5cm, 5 – 10 cm and more than 
10 centimetres. Type of performed surgery 
was noted, aim of surgery whether curative or 
palliative was also registered and so did the 
type of reconstruction after surgery. Post 
operative follow up of patients up to 30 days 
following surgery.  
Statistical analysis: 
Data was fed into Statistical Package of 
Social Sciences(SPSS). Means, correlations 
and One sample t-test were computed and 
statistical significance was taken at P = 0.05. 
 
Results: 
A total of 53 patients proved to have gastric 
cancer were studied. The males constituted 
30(56.6%).    
with a male to female ratio of 1.3:1. Mean 
age at presentation was 61.46 years for males 
and 51.43 years for females. Young patients 
“�40 years” were 9(17%) patients figure (1). 
The origin for 18(34%) patients was the 
Northern Region.  
 
Fig (1): Distribution of the study population 
according to age group 
Epigastric pain was the commonest 
presenting symptom seen in 47(88.7%) 
patients, followed by vomiting in 29(54.7%) 
patients as shown in table (1). Minimal 
duration of symptoms was one month in 
3(5.7%) patients, and the maximum was 24 
months in 1(1.9%) patient. However, the 
mean duration of symptoms in patients was 
5.2 months. 
Salted diet as a risk factor was obtained in 
only 2(3.8%) patients. However, 6(11.3%) 
patients used to take alcohol, 4(7.5%) patients 
were smokers and (5.6%) were snuffer, while 
3(5.6%) patients were both smoker and 
alcoholic.  
Family history of gastric cancer was obtained 
from one patient (1.9%). However, 23(43.4%) 
patients have associated co-morbidities such 
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as diabetes mellitus, hypertension, IHD, 
CRF…etc”. Past history of anaemia and 
blood transfusion was found in 34(64.15%) 
patients. The commonest type of blood was 
blood group O in 32(60.37%) patients.    
 
Table 1: Distribution of gastric malignancy 
patients according to symptoms 
Symptom Frequency % 
Abdominal pain 47 88.7% 
Dyspepsia  15 28.3% 
Anorexia  9 17 
Loss of weight 26 49.1% 
Heart Burn  6 11.3% 
Dysphagia  5 9.4% 
Regurgitation  2 3.8%
Vomiting  29 54.7% 
Haemtemesis 11 20.8% 
Malaena  16 30.2% 
Back Pain  5 9.4% 
Symptoms of 
anaemia  15 28.3% 
Small bowel 
obstruction  1 1.9%
The mean weight of patients at presentation 
was 57.3kg, 28(52.8%) patients were 
cachectic, 37(69.8%) patients were pale and 
23(43.4%) patients were dehydrated. 
Abdominal mass was found in 20(37.7%) 
patients and ascites was demonstrated in 
4(7.5%) patients. 
Investigations proved that 22(41.5%) patients 
had haemoglobin <10gm/dl, 24(45.3%) 
patients had hypokalaemia, and 5(9.4%) 
patients had impaired renal function. Albumin 
was low in 13(24.5%) patients. Chest x-Ray 
revealed consolidation and pleural effusion in 
5(9.4%) patients, and ECG ischaemic changes 
in 4(7.5%) patients.  
During endoscopy 33(62.3%) patients had 
antral lesions, 12(22.6%) had tumours in the 
cardia, and in 3(5.7%) patients the tumour 
was infiltrating whole stomach. The naked 
eye appearance was a cauliflower in 
37(69.8%), ulcer in 7(13.2%) and 6(11.3%) 
patients had gastric polyps. 
The histo-pathological examinations reported 
adenocarcinoma in 45(84.9%). Helicobacter 
testing through CLO “Cod liver oil” was 
positive in 33(97%) out of the 34 patients). 
However, 47(88.7%) patients were 
preoperatively transfused with blood, and the 
mean volume of blood received was 4.9 units 
per patient. Total number of patients who 
were fit for surgery was 41(77.4%) patients. 
They were 32(78%) patients with carcinoma, 
8(19.5%) patients had GIST and 1(2.41%) 
patient had carcinoid tumour.   
During the intra-operative assessment the 
tumour was infiltrating the pyloric antrum in 
27(65.85%) patients, while in 4(9.8%) patient 
the tumour was in the cardia. The body of the 
stomach was involved in 7(17.1%) patients 
and whole organ (pan-gastric) infiltration was 
seen in only 3(7.3%) patients. The operative 
staging is shown in Fig(2) . The size of the 
tumour was 5-10 cm in 27(65.9%) patients. 
Pancreatic invasion occurred in 16(39%) 
patients. 
Operative staging showed that 30(93.75%) 
out of 32 carcinoma patients were found to 
have advanced gastric cancer i.e. stage III –IV 
as depicted in fig (2). 
Therefore, palliative resection was performed 
in 28(68.3%) out of41 patients operated,The 
palliative resection was in the form of partial 
gastrectomy in 12(29.26%) patients, palliative 
total gastrectomy in 3(7.3%) patients, but, 
bypass “gastro-jejunostomy” was performed 
in 10(24.4%) patients and jejunostomy or 
gastrostomy feeding tube was inserted in 
another 3(7.3%) patients. However, extended 
gastrectomy was performed in only two cases. 
Curative surgery was contemplated in 
13(31.7%) patients. Curative total 
gastrectomy was done in 1(2.43%) patient, 
while curative partial resection was 
completed in 10(24.4%) patients. On the other 
side, extended gastrectomy with curative 
intention was carried out in 2(4.87%).   
The total number of patient who underwent 
partial gastrectomy for both curative and 
palliative purpose was 21(51.2%). Of them 
12(29.26%) patients had distal gastrectomy, 
5(12.19%) patients wide wedge resection and 
4(9.75%) patients proximal gastrectomy.   
Billroth II gastrectomy was the commonest 
reconstruction in 8(38.09%) patients. The 
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spleen was resected en-block with the tumour 
in 3(7.3%) patients, and the tail of the 
pancrease was resected in 1(2.43%) patient. 
Bilious vomiting occurred in 8(19.5%) 
patients. The frequency of postoperative 
complications are shown in table (2).  
The mean hospital stay for those who were 
operated was 12 days, and on discharge the 
symptomatic relief was satisfactory in 
28(80%) out of 41. The hospital mortality was 
4(7.5%) patients.  
 





Biliary vomiting  8 19.5% 
Fistula 2 4.9% 
Afferent loop syndrome 2 4.9%
Wound infection  1 2.4% 
No complications 28 68.3% 
Discussion: 
In this study we studied prospectively the data 
of 53 patients with gastric malignancies. 
These are consecutive patients who attended 
Ibn Sina Hospital for treatment in the period 
from August 2010 through August 2011. We 
noticed that carcinoma of the stomach has 
1.3:1. This is in keeping with the international 
literature2.
One decade before our study Khalid Al sir et 
al5 conducted  a retrospective study of 139 
patients admitted to the surgical unit at Ibn 
Sina Hospital with a diagnosis of gastric 
malignancies. In his study the male to female 
ratio was 2:1 compared to 1.3:1 in ours. 
However the male to female ratios in both 
studies is in keeping with the international 
literature. There was no change in the pattern 
of clinical presentation and tumour site. Also, 
the distal gastric tumours outnumber the 
proximal ones, and the palliative surgery is 
the commonest surgery for the majority of 
patients. The hospital mortality past these 
years had declined from12.5% in Khalid 
study to 7.5% in our study. This is possibly 
due to the improvement in managing critical 
cases that took place during the last years in 
Ibn Sina Hospital .See table (3). The highest 
frequency at the age group 55-70 years which 
is consistent with the published international 
reports6. However, in our study those who 
were younger than 40 years constituted 
16.98%. This is   rather     higher    than    the  
Fig (2): The frequency of the different stages 
of gastric cancer 
Fig (3): the frequency of the different 
modalities of the performed palliative surgery 
(n = 28) 
 
international reported percentage for this age 
group which is less than 5%6. We do not have 
specific explanation for this, therefore, 
genetic background and environmental factors 
need further studies in this aspect.  First 
degree relatives of gastric cancer have 2-3 
folds, increase risk of developing gastric 
cancer 7,8. Also, we found that family history 
of other malignancies like kidney, 
gynaecological, pancreas and biliary cancer in 
6(11.3%) patients. Here, we need future 
studies particularly concerned with genetics 
among Sudanese patients to define or validate 
our findings. Yet, Helicobacter pylori 
infection was present in 33 out of 34 patients 
tested. This is most likely a chronic disease in 
our patients and had probably existed since 
childhood.  Salted diet and partially cooked 
fish (Maloha) is common among patients of 
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northern origin. This could also be in 
agreement with the fact that salt is linked to 
H.pylori9.
Table (3): Comparison of the current study 
variables with 139 case study* of gastric 
malignancies conducted in Ibn Sina Hospital, 
1997-2004. 
 Current  
study 
Ibn Study in 
(1997-2004) 
Male: female ratio 1.3:1 2:1 
Age at peak 
frequency  
55-70 yrs. 50-65 yrs. 
Carcinoma 81.3% 84.8% 
GIST • 15% 4.4% 
Lymphoma  1.9% 5.8% 
Carcinoid 1.9% 0.7% 







Resectability 44.18% 62.6% 
Hospital mortality 7.5% 12.9% 
* Khalid Al sir, et al (-1997-2004). 
 
On the other hand, 32(60.4%) patients had the 
blood group O. This seems to be inconsistent 
with the reported predominance of the disease 
in patients with group A.  But, recently it had 
been proved that individuals with the blood 
group O were at risk of developing duodenal 
ulcers, gastric ulcer, and gastric 
malignancies10. Nonetheless, we found it 
interesting that one of our patients had 
carcinoma of the stump of the stomach 
following distal gastrectomy about 40 years 
before presentation. This could be explained 
by the effect of chronic bile reflux into the 
stump of the stomach11.
A total of 23(43.4%) of our patients have co-
morbid diseases and a total of 64.15%patients 
have anaemia that necessitated blood 
transfusion before and after surgery. All this 
could explain the rate of morbidity and 
mortality we had during the management of 
the population in this study.  
The majority of our patients i.e. 47(88.7%) 
presented with epigastric pain. This indicates 
that they presented at advanced stage.  
Vomiting was noted in 29(54.7%) patients. 
 
Fig (4): Results of histopathology 
 
This reflects the frequency of advanced 
disease causing obstruction. We found that 
there is significant statistical difference in the 
symptoms as related to the site of the tumour 
(P = 0.0020). Also cancer at the body of the 
stomach leads to significant blood loss (P = 
0.0090). Similarly carcinoma of the cardia 
leads to dysphagia (P = 0.0001). Sudan is one 
of the developing countries, where the 
intestinal distal gastric malignancy is still 
dominant over the proximal one, this could be 
linked to H. pylori infections12. In this link we 
have supporting evidence that H. pylori is a 
strong causative agent because 62.26% of our 
patients had H. pylori and that carcinoma of 
the antrum, body of stomach and diffuse 
gastric cancer was encountered in 65.85% 
17.07%, 7.31% respectively, making a total of 
90.23%. However the remaining cases i.e. 
9.75% who had carcinoma of the cardia of the 
stomach, may be due to the hypothesis that 
patients with H.pylori at a decrease risk of 
developing adenocarcinoma of the cardia, as 
H.pylori induce corpus gastritis, which 
decrease the acid secretion and creating a less 
damaging reflux and thus reduce the risk of 
Barrett’s oesophagus, the precursor lesion of 
the tumour13.
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Interestingly, one of our patients had one of 
the para-neoplastic features, acanthosis 
nigricans (dark pigmented lesion involving 
the skin and axilla) for which she sought 
medical advice and the endoscopy revealed 
the gastric cancer.  
Endoscopy was conclusive in 43(95.5%) 
patients, as there were two patients 
discovered to have GIST and carcinoid 
tumour after post operative histopathological 
examination.  
The eight patients (GIST) comprised 15% 
from the total number (n=53). This is higher 
than the reported the prevalence of gastric 
GIST.However, this is consistent with the 
previous report that GIST in Sudan is more 
common than Jordan14.
The operated patients were 41(77.4%). These 
were, 32(60.37%) patients with carcinoma, 
8(15.09%) GIST and 1(1.9%) was carcinoid. 
The resectability rate was 100% for GIST, 
44.18% for adenocarcinoma, and 100% for 
carcinoid. However, 28(68.3%) had palliative 
resection. This makes the potentially curative 
resection to be 13(31.7%). Limited 
lymphadenectomy, few dissected nodes and 
serosal involvement should be considered to 
be risk factors of postoperative recurrence of 
lymph node-negative gastric cancer patients15. 
Literature proves that the 5-year survival rate 
is influenced by the tumour size, gross type, 
serosal invasion, extragastric lymph node 
metastasis, liver metastasis, peritoneal 
dissemination, stage of disease (III and IV), 
involved resection margin, and operative 
curability (R0). Of these, independent 
prognostic factors were proven by literature 
are three tumour findings: serosal invasion, 
extragastric lymph node metastasis, and liver 
metastasis. However, the same literature 
reported that the survival was not 
significantly associated with any of the 
patient factors or type of operation and the 
extent of lymph node dissection16. Palliative 
chemotherapy was attempted in 8 patients 
(18.6%).   
All GIST patients and the single patient who 
had carcinoid tumour underwent curative 
resection. One lymphoma patient was referred 
to chemotherapy.  
The morbidity rate among this small series of 
patients is 13(24.6%). This morbidity rate is 
fairly comparable with that reported from 
Japan in a small number of patients 
comparable to the population size of our 
study. The Japanese researchers reported that 
"The study patients comprised 53 men 
(74.6%) and 18 women (25.4%) aged 39-89 
years (mean, 68.9 years). Nineteen patients 
(26.8%) had postoperative morbidity: 
pancreatic fistula developed in 6 patients 
(8.5%) and was the most frequent 
complication, followed by anastomosis 
stricture in 5 patients (7.0%). During the 
follow-up period, 28 patients (39.4%) died 
because of gastric cancer recurrence, and 3 
(4.2%) died because of another disease or 
accident.  
Hospital mortality (4 patients) (7.5%), they 
were all carcinoma with advanced disease.  
Our results are in keeping with a study 
performed in Korea. The Korean study 
reported that "Patients with T4 gastric 
carcinoma might be benefited from curative 
resection. The results also emphasize the 
improved survivorship of T4 gastric 
carcinoma patients with resection compared 
with those who did not undergo resection. 
Although curative resection cannot be 
undertaken in patients with T4 gastric 
carcinoma, we recommend performing 
resection in patients with locally advanced 
gastric carcinoma, regardless of curability17. 
The prognosis for gastric carcinoma patients 
with peritoneal dissemination is very poor. 
Yet they seem to benefit from resection 
followed by chemotherapy18. 
 
Conclusion: 
Adencarcinoma is the commonest 
histophathological type (81.13%) of gastric 
malignancies, followed by mesenchymal 
tumours (GIST) (15%) and the least common 
is carcinoid and gastric lymphoma.  Gastric 
antrum is the commonest site (65.85%) for 
this disease. H. pylori may play strong role   
in carcinoma of the stomach in our study. 
Indigestion, belching, and feeling of 
weakness and unexplained loss of weight are 
alarming signs. These symptoms are enough 
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to request gastroscopy if early gastric .cancer 
is to be diagnosed. Surgeons and 
gastroenterologists should have high index of 
suspicion for GIST tumours. There’s a 
significant group of patients less than 40 
years of age. In these cases genetic 
counselling is better to be advised and 
palliative surgery should not be denied to 
patients with advanced disease. Hospital 
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